< Browse more articles

With the escalating opioid crisis in Canada, overdose deaths shot up dramatically in 2016 and left governments, local emergency responders, and social workers desperate for solutions. Toxic opioid drugs like fentanyl and carfentanyl have made their way to several local communities, putting not just drug users, but first responders at risk.

In the wake of the crisis, law enforcement organizations are increasingly choosing to equip their front-line personnel with naloxone kits to treat opioid overdose victims and to help ensure that they are protected from accidental exposures to toxic drugs. On July 6, 2016 the Federal Health Minister Jane Philpott executed an Interim Order allowing NARCAN® naloxone Nasal Spray 4mg to be imported and sold in Canada.

In six months, 25,000 kits of NARCAN® have been ordered and distributed predominantly by law enforcement organizations, with the RCMP placing the largest orders. Corrections Canada and Border Services have also ordered NARCAN®, and Barrie Police in Ontario and Calgary Fire in Alberta were the latest local police departments to make an order.  

 “Adapt Pharma Canada is committed to ensuring access to our emergency treatment throughout the country. By putting it in the right hands, we can treat opioid overdoses in the communities in need of treatment and solutions.” said David Renwick, General Manager.

Adapt Pharma Canada has also made carrying cases available for NARCAN® to make it easier for first responders to carry the nasal spray. The case is designed to be easily attached to the first responder’s uniform or utility belt.

NARCAN® Nasal Spray offers 4 mg of naloxone concentrated in a small 0.1 milliliter spray and does not require a prescription. With the growing presence of illicit fentanyl and carfentanyl, there is a need to administer higher doses of naloxone to treat anyone who is overcome by these toxic drugs.

 

ADAPT 4C